Are tranexamic acid tablets useful in treating uterine bleeding?
Useful. As a synthetic lysine derivative, it has a high affinity with the lysine binding sites of plasminogen and plasmin, and can competitively inhibit the binding of lysine of fibrin to plasmin, thereby inhibiting the cleavage of fibrin, inhibiting the fibrinolysis process, and reducing the possibility of massive bleeding and recurrent bleeding.
Tranexamic acid tablets for the treatment of uterine bleeding
Eighty patients with irregular uterine bleeding (IUB) caused by DMPA who were admitted to the First Affiliated Hospital of China Medical University were selected and divided into a treatment group treated with tranexamic acid for 5 days and a placebo group treated with placebo for 5 days using the block randomization method, with 40 cases in each group. Follow-up observation was conducted for 4 weeks, and the number of hemostasis cases in 7 days, bleeding-free time in 28 days and the occurrence of adverse reactions were observed through the IUB information sheet reported by the patient.
Results: One case in the placebo group was lost to follow-up. In the treatment group, 33 subjects (82.5%) stopped bleeding within 7 days after taking the medication; in the placebo group, 10 subjects (25.6%) stopped bleeding within 7 days after taking the medication. The difference was statistically significant (P<0.05). The 28-day non-bleeding time of subjects in the treatment group was (20.73+4.07) d, and that of the placebo group was (11.90+5.78) d. The difference was statistically significant (P<0.05). One patient in the treatment group had mild nausea.
Conclusion
Tranexamic acid has significant efficacy in treating IUB caused by DMPA. In the experiment, it was found that the main symptoms include intracranial thrombosis, bleeding, diarrhea, nausea, vomiting, etc., and it is safe.
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
Recommended related articles:
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)